help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buijs, M. M.
Right arrow Articles by Pijl, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buijs, M. M.
Right arrow Articles by Pijl, H.
The Journal of Clinical Endocrinology & Metabolism Vol. 87, No. 12 5668-5674
Copyright © 2002 by The Endocrine Society


Original Article

Growth Hormone Blunts Protein Oxidation and Promotes Protein Turnover to a Similar Extent in Abdominally Obese and Normal-Weight Women

Madelon M. Buijs, Johannes A. Romijn, Jacobus Burggraaf, Marieke L. De Kam, Adam F. Cohen, Marijke Frölich, Frans Stellaard, A. Edo Meinders and Hanno Pijl

Department of General Internal Medicine (M.M.B., M.F., A.E.M., H.P.), Department of Endocrinology (J.A.R.), and Centre for Human Drug Research (J.B., M.L.D.K., A.F.C.), Leiden University Medical Centre, 2300 RC Leiden, The Netherlands; and Center for Liver, Digestive and Metabolic Diseases, Laboratory of Paediatrics (F.S.), University Hospital Groningen, 9713 GZ Groningen, The Netherlands

Address all correspondence and requests for reprints to: M. M. Buijs, M.D., Department of General Internal Medicine, Leiden University Medical Centre, C1-R39, P.O. Box 9600, 2300 RC Leiden, The Netherlands. E-mail: m.m.buijs{at}lumc.nl.

Abstract

Abdominally obese individuals have reduced 24-h plasma GH concentrations. Their normal plasma IGF-I levels may reflect GH hypersensitivity. Alternatively, obesity-associated hyposomatotropism may cause less biological effect in target tissues. We therefore determined whole-body responsiveness to the anabolic effects of GH in abdominally obese (OB) and normal weight (NW) premenopausal women. A 1-h iv infusion of GH or placebo was randomly administered to six NW (body mass index, 21.1 ± 1.9 kg/m2) and six OB (body mass index, 35.5 ± 1.5 kg/m2) women in a cross-over design. Endogenous insulin, glucagon and GH secretion was suppressed by infusion of somatostatin. Whole-body protein turnover was measured using a 10-h infusion of [13C]-leucine. GH administration induced a similar plasma GH peak in NW and OB women (49.8 ± 10.4 vs. 45.1 ± 5.6 mU/liter). GH, compared with placebo infusion, increased nonoxidative leucine disposal, P < 0.0001) and endogenous leucine appearance (Ra, P = 0.0004) but decreased leucine oxidation (P = 0.0051). All changes were similar in both groups. Accordingly, whole-body GH responsiveness, defined as the maximum response of nonoxidative leucine disposal, leucine Ra, and oxidation per unit of GH, was not different in OB and NW women (0.25 ± 0.18 vs. 0.19 ± 0.17 µmol/kg·h, 0.21 ± 0.23 vs. 0.13 ± 0.17 µmol/kg·h, and -0.10 ± 0.08 vs. -0.08 ± 0.05 µmol/kg·h, respectively). These results indicated that whole-body tissue responsiveness to the net anabolic effect of GH is similar in OB and NW women. Hence, we inferred that hyposomatotropism may promote amino acid oxidation and blunt protein turnover in abdominal obesity. However, hyposomatotropism cannot account for all anomalous features of protein metabolism in abdominally obese humans.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
K. R. Short, N. Moller, M. L. Bigelow, J. Coenen-Schimke, and K. S. Nair
Enhancement of Muscle Mitochondrial Function by Growth Hormone
J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 597 - 604.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
B. E. Engstrom, P. Burman, C. Holdstock, M. Ohrvall, M. Sundbom, and F A. Karlsson
Effects of gastric bypass on the GH/IGF-I axis in severe obesity - and a comparison with GH deficiency
Eur. J. Endocrinol., January 1, 2006; 154(1): 53 - 59.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Hansen, R. Morthorst, B. Larsson, A. Flyvbjerg, M. H. Rasmussen, H. Orskov, A. Astrup, M. Kjaer, and K. H. W. Lange
Effects of 2 wk of GH administration on 24-h indirect calorimetry in young, healthy, lean men
Am J Physiol Endocrinol Metab, December 1, 2005; 289(6): E1030 - E1038.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. M. Buijs, J. A. Romijn, J. Burggraaf, M. L. de Kam, M. Frolich, M. T. Ackermans, H. P. Sauerwein, A. F. Cohen, A. E. Meinders, and H. Pijl
Glucose homeostasis in abdominal obesity: hepatic hyperresponsiveness to growth hormone action
Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E63 - E68.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society